ANB-002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ANB-002, covering 2025-06-13 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B [Phase 3]